Stay Informed of our Latest Innovations.
Report aims to identify list of critically required diagnostic tests.
Recently, the World Health Organization published its first Essential Diagnostics List, a catalogue of the tests needed to diagnose the most common conditions as well as a number of global priority diseases.
Today, many people are unable to get tested for diseases because they cannot access diagnostic services. Many are incorrectly diagnosed. As a result, they do not receive the treatment they need and, in some cases, may actually receive the wrong treatment.
Caseloads have nearly doubled as outbreaks spread nationwide.
A severe but localized hepatitis A outbreak in San Diego last fall has moved east across multiple state lines and shows no sign of slowing down. Cases of hepatitis A in the United States have nearly doubled since this time last year, even as public health officials have worked to stem the tide of infections through vaccine campaigns and community education.
The development of immunoassays has revolutionized laboratory medicine, especially during the last 30 years. The implementation of new endpoint tracers, new assay formats, automatization, reproducibility, duration time of assay and availability of analyses have contributed for immunoassays to become everyday practice.
The FDA has recently alerted the public, health care providers, lab personnel, and lab test developers that biotin can significantly interfere with certain lab tests and cause incorrect test results which may go undetected. Many lab tests use biotin technology due to its ability to bond with specific proteins which can be measured to detect certain health conditions. For example, biotin is used in hormone tests and tests for markers of cardiac health like troponin.